Back to Trades
Shah Gaurav
CEOCIK 0001725922
Total Volume
$545.7K
9 filings
Purchases
$0
0 buy txns
Sales
$280.2K
8 sell txns
Net Activity
-$280.2K
net sold
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 9
- Buy transactions
- 0
- Sell transactions
- 8
- Companies
- 1
- Active
- 2025–2026
Across 9 filings between 2025–2026, Shah Gaurav, CEO, has disclosed $545.7K in transactions — all concentrated in ROCKET PHARMACEUTICALS, INC. (RCKT). Their disclosed trades are heavily weighted toward selling — $0 in buys and $280.2K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
9 loaded
| Nov 20 | RCKT ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO | Sell | $4.8K |
| Nov 17 | RCKT ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | Insider | Sell | $6.8K |
| Aug 20 | RCKT ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | Insider | Sell | $7.8K |
| Aug 17 | RCKT ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | Insider | Sell | $9.6K |
| May 26 | RCKT ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | Insider | Sell | $171.8K |
| Feb 20 | RCKT ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | Insider | Sell | $20.0K |
| Feb 18 | RCKT ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | Insider | Sell | $40.7K |
| Nov 20 | RCKT ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | Insider | Sell | $18.7K |
| Aug 20 | RCKT ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | Insider | Tax withheld | $6.8K |
9 filings